Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    87,672.88
    +3,631.12 (+4.32%)
     

  • CMC Crypto 200

    1,368.95
    +56.33 (+4.29%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Company News for August 19, 2016

Zacks Equity Research
Updated

•    Shares of Cisco Systems, Inc. (CSCO) dropped 0.8% after the network equipment provider declared that it will trim 5,500 jobs

•    Shares of NetApp, Inc. (NTAP) soared 17.4% after the company posted fiscal first quarter earnings per share of $0.28 beating the Zacks Consensus Estimate of $0.18

•    Shares of Hormel Foods Corporation (HRL) gained 1.9% after the company reported third-quarter fiscal 2016 earnings per share of $0.36 that beat the Zacks Consensus Estimate of $0.34

•    Valeant Pharmaceuticals International, Inc.’s (VRX) shares dropped 2.7% after T. Rowe Price Group, Inc. (TROW) alleged that Valeant Pharmaceuticals was involved in “a fraudulent scheme” that cost T.Rowe’s investors billions of dollars


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CISCO SYSTEMS (CSCO): Free Stock Analysis Report
 
NETAPP INC (NTAP): Free Stock Analysis Report
 
HORMEL FOODS CP (HRL): Free Stock Analysis Report
 
VALEANT PHARMA (VRX): Free Stock Analysis Report
 
T ROWE PRICE (TROW): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research